TABLE 3

Affinity of LDT3, LDT5, and LDT8 for rat 5-HT1A receptors

CompoundKi High, nM (n)Ki Low, nM (n)Ki Low/Ki High
[pKi ± SD][pKi ± SD][95% C.I.]
LDT31.12 (4)1.73 (3)1.53
[8.95 ± 0.07]***[8.76 ± 0.19]*[1.02–2.81]
LDT52.51 (4)6.91 (3)2.75
[8.60 ± 0.05]***[8.16 ± 0.13]***[1.68–4.50]
LDT80.009 (2)0.62 (3)66.9
[11.05 ± 0.03][9.21 ± 0.07][45.0–99.8]
LDT66a5.9 (4)10.2 (4)1.71
[8.23 ± 0.3]***[7.99 ± 0.1]***[0.32–9.20]
5-HTa3.02 (3)213 (6)76.8
[8.52 ± 0.03][6.67 ± 0.15][40.5–146]
  • Ki values were determined in competition-binding assays with the agonist [3H]8-OH-DPAT (Ki High) or antagonist [3H]p-MPPF (in the presence of high GTP; Ki Low), using membrane preparations of rat hippocampus. pKi values (i.e., −log Ki) were expressed as arithmetic means and S.D. of (n) experiments. The Ki Low/Ki High ratio is an estimate of the intrinsic activity toward 5-HT1A receptors, where values significantly higher than 1 indicate agonist activity (5-HT, was used as an example of full agonist), whereas values close to 1 indicate antagonist activity. The 95% confidence intervals (C.I.) of the Ki ratios were calculated as previously described (Noël et al., 2014).

  • F3,10 = 1471, P < 0.0001 for Ki High. ***P < 0.001 compared with LDT8 (one-way ANOVA for LDTs followed by a post hoc Dunnett’s test).

  • F3,9 = 55.97, P < 0.0001 for Ki Low. *P < 0.05, ***P < 0.001 compared with LDT8 (one-way ANOVA for LDTs followed by a post hoc Dunnett’s test).

  • a Data from Chagas-Silva et al., 2014 with permission.